Pharmaceuticals

GxP-compliant AI for Pharmaceutical Manufacturing

Basetwo enables pharmaceutical manufacturers to maximize quality, improve yields, and reduce cycle times at each stage of production.

Book a Demo

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oops, this looks like a personal email. Please enter a business email address
Fed-Batch BioreactorBR-101
Sparging air37.0 °C
Agitation90rpm
Dissolved O₂100% sat
pH7.20
VCD0.4×10⁶/mL
Growth curveVCDDO

Trusted by 6 of the top 20 pharmaceutical companies worldwide

FDA 21 CFR Part 11ALCOA+ data integrityGMP-validated workflowsInspection-ready audit trailsSOC 2 Type II

Basetwo helps process development and manufacturing teams predict and optimize process outcomes.

Process Development

Upstream · Downstream
TodayWith Basetwo
Long development timelines due to uncertain scale-up dynamicsPredict performance at the target scale before your next run
Screening is limited by scarce material, from viral vector to early APIVirtual experiments get more from every gram of material
Trial-and-error DoEs are a significant experimental burdenBasetwo proposes the experiments worth running

MSAT & Manufacturing Operations

Upstream · Downstream
TodayWith Basetwo
Process deviations are only identified when sampling occursAnticipate process drift in real time to prevent out-of-spec batches
Tech transfer to a new site restarts process learningModels built in PD carry into the plant and across sites
In-process control requires expensive PAT hardware, calibration and maintenanceModel-driven "soft sensors" learn from process data directly without spectral sensors
Each deviation investigated from scratchPast deviations can be used to identify process patterns
Your process

See what Basetwo does for your modality.

01 · Modality
Protein Biologics
Genetic Medicines
Small Molecule
Synthetic & Hybrid
02 · Department
Viral vectors · Process Development
Upstream·Bioreactor
Low, variable titers
Model transfection and production kinetics to find conditions that lift titers and narrow run-to-run spread.
Downstream·AEX separation
Full/empty separation
Model the separation step to set conditions that improve full/empty capsid resolution with fewer runs.
Upstream·Bioreactor
Optimized Bioreactor Development
Fit a hybrid bioreactor model to your existing Ambr runs, then test feed, media, clone and process conditions virtually so only the best go to the next scale.
Downstream·Chromatography
Material-limited screening
Model chromatography and filtration steps from small-scale data to screen resins and column conditions without consuming scarce material.
Book a Demo Read Case Studies

Pharmaceutical workflows running on Basetwo.

Purpose-built deployments for drug substance and drug product manufacturing.

Virtual experimentation app comparing three fed-batch experiments and their predicted final titer

Process Development

Process Development

Run virtual experiments on hybrid models of your upstream and downstream unit operations to find optimal process parameters with fewer lab runs.

End of batch titer prediction dashboard following a live run against the model fit

Predictive Quality Control

Manufacturing

Predict end-of-batch titer, purity and other CQAs from live GMP process data, so QA can act before a batch goes out of spec.

Scale-up comparison between an Ambr 250 and a 2,000L bioreactor

Scale Up

Process Development

Carry mixing, mass transfer and gassing performance from Ambr and bench scale to commercial bioreactors and API vessels.

Tech transfer comparison of sending and receiving site batch data

Tech Transfer

Process Development

Transfer validated process models from development to a CMO or second manufacturing site and match performance in the first batches.

Root cause analysis attributing a low titer deviation to its process causes

Root Cause Analysis

Manufacturing

Trace an out-of-spec batch to its process causes and support deviation investigations with model evidence.

Clone SelectionCell Line Development
Bioreactor Gassing StrategyScale Up
Titer PredictionGMP
Feed/Media OptimizationProcess Development
Perfusion SystemsTech Transfer
Crystallization PSD ControlManufacturing
Virtual Experimentation DesignProcess Development
Solvent Swap DistillationManufacturing
Security & Compliance

GMP-validated, compliant with FDA 21 CFR Part 11.

Keep your process data and models secure, controlled and traceable, from the first development model to the batches it supports in GMP.

Maintain Data Integrity & Traceability

Complete audit trails across data, models, and decisions, compliant with FDA 21 CFR Part 11 and ALCOA+ standards.

Validated for GMP Workflows

GMP-aligned verification, change control, and continuous monitoring ensure reliable and compliant AI outputs.

Regulatory-Ready Documentation

Export structured logs, audit trails, and model evidence that support FDA inspections and validation workflows.

Operate Within a Secure Environment

Role-based access, controlled environments, and enterprise-grade security safeguard data for regulated manufacturing.

BasetwoProjects / Fed-batch titer / Regulatory packageQA
Regulatory packageExport PDF
Model v3 · Fed-batch titerICH Q8 / Q11
1
Design spaceFeed rate × temperature, 3 CPPs
Ready
2
CharacterizationSensitivity, edge of failure
Ready
3
Model validationR² 0.96 on 8 held-out runs
Ready
4
Change historyv1 → v3, approved
Signed
QAApproved and e-signed by QA · audit trail attached
FDA 21 CFR Part 11ALCOA+ data integrityGMP-validated workflowsInspection-ready audit trailsSOC 2 Type II
Learn about security & compliance
What teams tell us

Built with process teams at top pharmaceutical companies.

“This platform empowers experts to create models and share results in a user-friendly way.”

Director of Digital TransformationFortune 100 Pharmaceutical Company

“It usually takes me a couple of hours to get datasets lined up together but it only took a few minutes on Basetwo”

Process EngineerTop Pharmaceutical Company Globally

“Basetwo’s hybrid models provided insights into our “black box” processes, allowing engineers to understand and maximize quality even with limited sensor coverage.”

Director of Digital TransformationFortune 100 Pharmaceutical Company
For CDMOs

Many molecules, many clients, faster tech transfer.

Reuse process knowledge across programs, transfer client processes into your plants faster and back proposals with model-based evidence. Most relevant for viral vectors, cell therapy, mRNA, oligos and peptides, and ADCs.

Start each new client program from models trained on similar processes
Keep each client's data and models separated with role-based access
Share model-based evidence with clients during proposals and transfer
BasetwoWorkspaces / Client programsQA
Active tech transfersAll sites5 programs
ProgramModalitySiteStatus
AAV-204 gene therapyClient A
Viral vectorSite 2 · 500LModel reused
CAR-T autologousClient B
Cell therapySite 1In transfer
mRNA-LNP vaccineClient C
mRNA / LNPSite 3Validated
GLP-1 peptideClient D
PeptideSite 2Validated
ADC-17 conjugateClient E
ADCSite 1Model reused

See Basetwo on your modality.

Tell us your modality and process stage. We’ll walk through a model built for that problem.

Schedule a Demo Today